Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Added Value from Secondary Use of Person Generated Health Data in Consumer Health Informatics.

Hsueh PY, Cheung YK, Dey S, Kim KK, Martin-Sanchez FJ, Petersen SK, Wetter T.

Yearb Med Inform. 2017 Aug;26(1):160-171. doi: 10.15265/IY-2017-009. Epub 2017 Sep 11.

2.

R-α-lipoic acid does not reverse hepatic inflammation of aging, but lowers lipid anabolism, while accentuating circadian rhythm transcript profiles.

Finlay LA, Michels AJ, Butler JA, Smith EJ, Monette JS, Moreau RF, Petersen SK, Frei B, Hagen TM.

Am J Physiol Regul Integr Comp Physiol. 2012 Mar 1;302(5):R587-97. doi: 10.1152/ajpregu.00393.2011. Epub 2011 Nov 2.

3.

[Basal cell adenocarcinoma of the sublingual gland].

Petersen SK, Bjørndal K, Krogdahl A, Godballe C.

Ugeskr Laeger. 2010 Feb 15;172(7):551-2. Danish.

PMID:
20156409
4.

No-fault and enterprise liability: the view from Utah.

Petersen SK.

Ann Intern Med. 1995 Mar 15;122(6):462-3. No abstract available.

PMID:
7856996
5.
6.

Characterization of toxin from different strains of Pasteurella multocida serotype A and D.

Frandsen PL, Foged NT, Petersen SK, Bording A.

Zentralbl Veterinarmed B. 1991 Jul;38(5):345-52.

PMID:
1927149
7.

Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.

Nielsen JP, Foged NT, Sørensen V, Barfod K, Bording A, Petersen SK.

Can J Vet Res. 1991 Apr;55(2):128-38.

8.

Recombinant derivatives of Pasteurella multocida toxin: candidates for a vaccine against progressive atrophic rhinitis.

Petersen SK, Foged NT, Bording A, Nielsen JP, Riemann HK, Frandsen PL.

Infect Immun. 1991 Apr;59(4):1387-93.

10.

Supplemental Content

Loading ...
Support Center